D-241-2013 Class III Terminated

Recalled by Fougera Pharmaceuticals Inc. — Melville, NY

FDA drug recall D-241-2013 was initiated by Fougera Pharmaceuticals Inc. on Jul 18, 2012 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant product The recall status is terminated (terminated Dec 10, 2015). Affected quantity: 60,210 units.

Recall details

Product Type
Drugs
Report Date
Apr 10, 2013
Initiation Date
Jul 18, 2012
Termination Date
Dec 10, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60,210 units

Product description

Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-15

Reason for recall

Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant product

Distribution pattern

Nationwide

Code information

Lot #: 835H, Exp 07/12

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-241-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-241-2013. Report a data issue: hello@regdatalab.com.